Agilent Technologies, Inc. (NYSE:A) Stock Holdings Lessened by New York State Common Retirement Fund

New York State Common Retirement Fund lowered its stake in Agilent Technologies, Inc. (NYSE:A) by 10.1% during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 333,623 shares of the medical research company’s stock after selling 37,597 shares during the period. New York State Common Retirement Fund owned approximately 0.12% of Agilent Technologies worth $39,027,000 as of its most recent filing with the SEC.

Several other institutional investors also recently modified their holdings of A. Redwood Park Advisors LLC acquired a new stake in Agilent Technologies during the 4th quarter valued at $27,000. Lee Danner & Bass Inc. acquired a new stake in Agilent Technologies during the 4th quarter valued at $29,000. Sunbelt Securities Inc. raised its stake in Agilent Technologies by 640.0% during the 4th quarter. Sunbelt Securities Inc. now owns 222 shares of the medical research company’s stock valued at $30,000 after purchasing an additional 192 shares during the period. Whipplewood Advisors LLC raised its stake in Agilent Technologies by 286.2% during the 1st quarter. Whipplewood Advisors LLC now owns 251 shares of the medical research company’s stock valued at $29,000 after purchasing an additional 186 shares during the period. Finally, Wood Tarver Financial Group LLC acquired a new stake in Agilent Technologies during the 4th quarter valued at $34,000.

Insider Buying and Selling at Agilent Technologies

In other news, CEO Padraig Mcdonnell sold 1,508 shares of the stock in a transaction that occurred on Tuesday, July 1st. The shares were sold at an average price of $117.44, for a total transaction of $177,099.52. Following the sale, the chief executive officer directly owned 37,448 shares of the company’s stock, valued at $4,397,893.12. This represents a 3.87% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Analysts Set New Price Targets

A has been the topic of a number of research reports. Wells Fargo & Company dropped their price target on shares of Agilent Technologies from $155.00 to $135.00 and set an “overweight” rating on the stock in a research note on Thursday, April 17th. TD Cowen upped their price target on shares of Agilent Technologies to $150.00 and gave the stock a “buy” rating in a research note on Thursday, May 29th. Evercore ISI upped their price target on shares of Agilent Technologies from $125.00 to $130.00 and gave the stock an “in-line” rating in a research note on Tuesday, July 8th. UBS Group dropped their price target on shares of Agilent Technologies from $150.00 to $130.00 and set a “neutral” rating on the stock in a research note on Thursday, May 29th. Finally, Robert W. Baird dropped their price target on shares of Agilent Technologies from $159.00 to $140.00 and set an “outperform” rating on the stock in a research note on Thursday, May 22nd. Six investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $139.77.

Agilent Technologies Stock Performance

NYSE:A opened at $120.10 on Tuesday. Agilent Technologies, Inc. has a 12-month low of $96.43 and a 12-month high of $153.84. The company has a quick ratio of 1.60, a current ratio of 2.09 and a debt-to-equity ratio of 0.55. The firm has a market capitalization of $34.12 billion, a PE ratio of 29.65, a price-to-earnings-growth ratio of 3.74 and a beta of 1.23. The firm has a 50-day moving average price of $115.47 and a 200 day moving average price of $122.55.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Wednesday, May 28th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.26 by $0.05. The firm had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.63 billion. Agilent Technologies had a net margin of 17.59% and a return on equity of 25.92%. The company’s quarterly revenue was up 6.0% compared to the same quarter last year. During the same quarter in the prior year, the business posted $1.22 earnings per share. Research analysts anticipate that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 23rd. Stockholders of record on Tuesday, July 1st will be issued a dividend of $0.248 per share. This represents a $0.99 annualized dividend and a dividend yield of 0.83%. The ex-dividend date is Tuesday, July 1st. Agilent Technologies’s payout ratio is 24.44%.

Agilent Technologies Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.